Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.56 |
| ▸ | PPARG | P37231 | 5/20 | 0.54 |
| ▸ | PPARA | Q07869 | 5/20 | 0.54 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | TOP1 | P11387 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4751614 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL5498298 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL8083753 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL5498294 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL4751612 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL8083757 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL3345152 | 1.00 | PTPN1 (0.56) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL15515132 | 0.98 | PTPN1 (0.53) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL15515133 | 0.98 | PTPN1 (0.53) | PTPN1PPARGPPARATERTPPARD | |
| SCHEMBL8075370 | 0.87 | FASN (0.59) | PTPN1PPARGPPARATERTPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9854799-B2 | Means and methods for rhamnolipid production | AMLIKA MERCANTILE PRIVATE LIMITED (IN) | 2018-01-02 | — | — | US | claimed |
| US-20140235561-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | AMLIKA MERCANTILE PRIVATE LIMITED (IN) | 2014-08-21 | — | — | US | claimed |
| EP-2758526-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | Heinrich-Heine-Universität (DE) | 2014-07-30 | — | — | EP | claimed |
| WO-2014039940-A1 | CELLS AND METHODS FOR THE PRODUCTION OF RHAMNOLIPIDS | LOGOS TECHNOLOGIES LLC (US) | 2014-03-13 | — | — | WO | claimed |
| WO-2013041670-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | HEINRICH-HEINE-UNIVERSITAET (DE) | 2013-03-28 | — | — | WO | claimed |
| EP-2573172-A1 | Means and methods for rhamnolipid production | Heinrich-Heine-Universität Düsseldorf (DE) | 2013-03-27 | — | — | EP | claimed |
| EP-1044278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 2000-10-18 | — | — | EP | claimed |
| WO-1999035278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1999-07-15 | — | — | WO | claimed |
| US-9854799-B2 | Means and methods for rhamnolipid production | AMLIKA MERCANTILE PRIVATE LIMITED (IN) | 2018-01-02 | — | — | US | disclosed |
| EP-2791327-B1 | FOAM ADSORPTION | AMLIKA MERCANTILE PRIVATE LTD (AMPL) (IN) | 2017-08-30 | — | — | EP | disclosed |
| CN-104822835-A | Eco-friendly plasticizer for poly(vinyl chloride) | UNIVERSITI MALAYA U M | 2015-08-05 | — | — | CN | disclosed |
| US-20150011741-A1 | FOAM ADSORPTION | TECHNISCHE UNIVERSITAET DORTMUND (DE) | 2015-01-08 | — | — | US | disclosed |
| EP-2791327-A1 | FOAM ADSORPTION | Technische Universität Dortmund (DE) | 2014-10-22 | — | — | EP | disclosed |
| US-20140235561-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | AMLIKA MERCANTILE PRIVATE LIMITED (IN) | 2014-08-21 | — | — | US | disclosed |
| WO-2013041670-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | HEINRICH-HEINE-UNIVERSITAET (DE) | 2013-03-28 | — | — | WO | disclosed |
| EP-2573172-A1 | Means and methods for rhamnolipid production | Heinrich-Heine-Universität Düsseldorf (DE) | 2013-03-27 | — | — | EP | disclosed |
| WO-2010044118-A1 | PRODUCTION OF BIODEGRADABLE PLASTICS FROM BRASSICA CARINATA OIL WITH HIGH CONTENT OF ERUCIC ACID AND FROM VERY LONG CHAIN FATTY ACIDS | BALLISTRERI ALBERTO (IT) | 2010-04-22 | — | — | WO | disclosed |
| WO-2008135065-A1 | PHAs PRODUCING MICROORGANISM AND PHA OBTAINABLE THEREWITH | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2008-11-13 | — | — | WO | disclosed |
| EP-1044278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 2000-10-18 | — | — | EP | disclosed |
| WO-1999035278-A1 | BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES | MONSANTO COMPANY (US) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011741-A1 | FOAM ADSORPTION | FABP4, CETP, NPC1L1 | PTPN1 4664/4885PPARG 218/4885PPARA 216/4885 |
| US-20140235561-A1 | MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION | MRPL21, CMBL, MGLL | PTPN1 4344/4885PPARG 3369/4885PPARA 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.